Qualigen Therapeutics Inc. (AIXC)
NASDAQ · Healthcare
Qualigen Therapeutics Inc. Operating Income 2020–2022
Qualigen Therapeutics Inc. annual/quarterly operating income history and growth rate from 2020 to 2023. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Qualigen Therapeutics Inc. operating income for the quarter ending June 30, 2023 was -3.6 M, a 13.03% decrease year-over-year.
- Qualigen Therapeutics Inc. operating income for the twelve months ending June 30, 2023 was -13.9 M, a 39.79% decrease year-over-year.
- Qualigen Therapeutics Inc. annual operating income for 2022 was -14.8 M, a 34.87% decrease from 2021.
- Qualigen Therapeutics Inc. annual operating income for 2021 was -22.7 M, a 1407.65% increase from 2020.
- Qualigen Therapeutics Inc. annual operating income for 2020 was -1.5 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Qualigen Therapeutics Inc. Operating Income — FAQ
Qualigen Therapeutics Inc. (AIXC) operating income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Qualigen Therapeutics Inc.'s operating income?
Qualigen Therapeutics Inc. (AIXC) reported operating income of -$15M for fiscal 2022.
Where can I see AIXC's operating income history?
The chart and table above show Qualigen Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.